Conatus Global Opens the Door for Lucrative Funding from Top Tier Venture CapitalistsNewsfile Corp • 08/07/23
Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic AlopeciaGlobeNewsWire • 05/11/20
The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020GlobeNewsWire • 05/07/20
Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/06/19
Conatus Pharmaceuticals (CNAT) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/31/19
Conatus (CNAT) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 08/19/19
Conatus Pharmaceuticals (CNAT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/19
Will Conatus Pharmaceuticals (CNAT) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/31/19
Conatus (CNAT) Down 5.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/01/19
Conatus Pharmaceuticals (CNAT) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/02/19
Conatus Pharmaceuticals (CNAT) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/24/19